RPE atrophy following photodynamic therapy in type 2A idiopathic parafoveal telangiectasis.
We report a case of Type 2A idiopathic parafoveal telangiectasis treated by Photodynamic Therapy (PDT), resulting in retinal pigment epithelial (RPE) atrophy corresponding to the size of the laser spot used. This raises a doubt regarding the safety of photodynamic therapy in CNVM secondary to type 2A parafoveal telangiectasis.
Shanmugam
Mahesh P
MP
Medical and Vision Research Foundations, Sankara Nethralaya, 18 College Road, Chennai 600-006, Tamil Nadu, India. mrf@sankaranethralaya.org
Agarwal
Manisha
M
D001284:Atrophy; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000209:etiology* / Q000473:pathology; D005584:Fovea Centralis; D005654:Fundus Oculi; D006801:Humans; D008297:Male; D008875:Middle Aged; D010778:Photochemotherapy / Q000009:adverse effects*; D017319:Photosensitizing Agents / Q000627:therapeutic use; D010857:Pigment Epithelium of Eye / Q000473:pathology*; D013684:Telangiectasis / Q000145:classification / Q000150:complications / Q000188:drug therapy*
D017319:Photosensitizing Agents